Moderna
MRNA
#1365
Rank
โ‚น1.129 T
Marketcap
โ‚น2,923
Share price
4.62%
Change (1 day)
-68.33%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: โ‚น1.129 Trillion

As of March 2025 Moderna has a market cap of โ‚น1.129 Trillion. This makes Moderna the world's 1365th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚น1.129 T-14.71%
2024โ‚น1.324 T-58.03%
2023โ‚น3.156 T-44.72%
2022โ‚น5.710 T-25.5%
2021โ‚น7.664 T153.51%
2020โ‚น3.023 T544.07%
2019โ‚น469.41 B33.71%
2018โ‚น351.06 B

End of Day market cap according to different sources

On Mar 23rd, 2025 the market cap of Moderna was reported to be:

โ‚น1.077 Trillion
by Nasdaq info icon info icon
โ‚น1.080 Trillion
by CompaniesMarketCap info icon info icon
โ‚น1.080 Trillion
by Yahoo Finance info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚น8.15 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.944 T 1,665.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น71.26 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.218 T 184.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.838 T 1,567.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น182.04 B-83.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.657 T 2,878.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น254.68 B-77.46%๐Ÿ‡บ๐Ÿ‡ธ USA